Long-term effects of vagus nerve stimulation in refractory pediatric epilepsy: A single-center experience
- PMID: 32604021
- DOI: 10.1016/j.yebeh.2020.107147
Long-term effects of vagus nerve stimulation in refractory pediatric epilepsy: A single-center experience
Abstract
Introduction: Vagus nerve stimulation (VNS) has been used as an adjunctive therapy for both children and adults with refractory epilepsy, over the last two decades. In this study, we aimed to evaluate the long-term effects and tolerability of VNS in the pediatric drug-resistant epilepsy (DRE) and to identify the predictive factors for responsiveness to VNS.
Methods: We retrospectively reviewed the medical records of pediatric patients who underwent VNS implantation between 1997 and 2018. Patients with ≥50% reduction of seizure frequency compared with the baseline were defined as "responders". The clinical characteristics of responders and nonresponders were compared.
Results: A total of 58 children (male/female: 40/18) with a mean follow-up duration of 5.7 years (3 months to 20 years) were included. The mean age at implantation was 12.4 years (4.5 to 18.5 years). Approximately half (45%) of our patients were responders, including 3 patients (5.8%) who achieved seizure freedom during follow-up. The age of seizure-onset, duration of epilepsy, age at implantation, and etiologies of epilepsy showed no significant difference between responders and nonresponders. Responders were more likely to have focal or multifocal epileptiform discharges (63%) on interictal electroencephalogram (EEG), when compared to nonresponders (36%) (p = .07). Vocal disturbances and paresthesias were the most common side effects, and in two patients, VNS was removed because of local reaction.
Conclusion: Our series had a diverse etiological profile and patients with transition to adult care. Long-term follow-up showed that VNS is an effective and well-tolerated treatment modality for refractory childhood onset epilepsy. Age at implantation, duration of epilepsy and underlying etiology are not found to be predictors of responsiveness to VNS. Higher response rates were observed for a subset of patients with focal epileptiform discharges.
Keywords: Drug-resistant epilepsy; Pediatric; Vagus nerve stimulation.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors have declared that no conflict of interest exits.
Similar articles
-
The role of vagus nerve stimulation in genetic etiologies of drug-resistant epilepsy: a meta-analysis.J Neurosurg Pediatr. 2022 Mar 18;29(6):667-680. doi: 10.3171/2022.1.PEDS222. Print 2022 Jun 1. J Neurosurg Pediatr. 2022. PMID: 35303699 Review.
-
The Effectiveness of Vagus Nerve Stimulation in Drug-Resistant Epilepsy Correlates with Vagus Nerve Stimulation-Induced Electroencephalography Desynchronization.Brain Connect. 2020 Dec;10(10):566-577. doi: 10.1089/brain.2020.0798. Epub 2020 Nov 18. Brain Connect. 2020. PMID: 33073582 Free PMC article.
-
Chronic vagus nerve stimulation reverses heart rhythm complexity in patients with drug-resistant epilepsy: An assessment with multiscale entropy analysis.Epilepsy Behav. 2018 Jun;83:168-174. doi: 10.1016/j.yebeh.2018.03.035. Epub 2018 Apr 27. Epilepsy Behav. 2018. PMID: 29709876
-
An interictal EEG can predict the outcome of vagus nerve stimulation therapy for children with intractable epilepsy.Childs Nerv Syst. 2017 Jan;33(1):145-151. doi: 10.1007/s00381-016-3261-5. Epub 2016 Oct 6. Childs Nerv Syst. 2017. PMID: 27714458
-
Rates and Predictors of Seizure Freedom With Vagus Nerve Stimulation for Intractable Epilepsy.Neurosurgery. 2016 Sep;79(3):345-53. doi: 10.1227/NEU.0000000000001165. Neurosurgery. 2016. PMID: 26645965 Free PMC article. Review.
Cited by
-
Analysis of factors influencing the efficacy of vagus nerve stimulation for the treatment of drug-resistant epilepsy in children and prediction model for efficacy evaluation.Front Neurol. 2024 Feb 14;15:1321245. doi: 10.3389/fneur.2024.1321245. eCollection 2024. Front Neurol. 2024. PMID: 38419715 Free PMC article.
-
Vagus nerve stimulation for treating developmental and epileptic encephalopathy in young children.Front Neurol. 2023 Oct 20;14:1191831. doi: 10.3389/fneur.2023.1191831. eCollection 2023. Front Neurol. 2023. PMID: 37928141 Free PMC article.
-
Effects of Stable Vagus Nerve Stimulation Efficacy on Autistic Behaviors in Ten Pediatric Patients With Drug Resistant Epilepsy: An Observational Study.Front Pediatr. 2022 Mar 2;10:846301. doi: 10.3389/fped.2022.846301. eCollection 2022. Front Pediatr. 2022. PMID: 35311037 Free PMC article.
-
Efficacy and potential predictors of vagus nerve stimulation therapy in refractory postencephalitic epilepsy.Ther Adv Chronic Dis. 2022 Jan 13;13:20406223211066738. doi: 10.1177/20406223211066738. eCollection 2022. Ther Adv Chronic Dis. 2022. PMID: 35070253 Free PMC article.
-
Vagus nerve stimulation: a 20-year Australian experience.Acta Neurochir (Wien). 2022 Jan;164(1):219-227. doi: 10.1007/s00701-021-05046-0. Epub 2021 Nov 10. Acta Neurochir (Wien). 2022. PMID: 34755209
MeSH terms
LinkOut - more resources
Full Text Sources
Medical